Investing.com - Xenon Pharmaceuticals reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Xenon Pharmaceuticals announced earnings per share of $-0.57 on revenue of $130K. Analysts polled by Investing.com anticipated EPS of $-0.51 on revenue of $4.15M.
Xenon Pharmaceuticals shares are down 35% from the beginning of the year , still down 14.47% from its 52 week high of $41.39 set on Thursday, August 11, 2022.
Xenon Pharmaceuticals follows other major Healthcare sector earnings this month
Xenon Pharmaceuticals's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar